Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine after it had initially refused to do so, citing flaws in the trial design.The FDA has accepted Moderna’s revised approach seeking full approval for the shot for adults…
25 Aprile a Milano, Meghnagi: “L’Anpi non voleva gli ebrei”. La replica: “Parole farneticanti”
Read More [#item_full_content]